Company will present vital findings at SRI annual meeting
Category: News
New stroke therapy delivers electrical pulses to the brain
Green light concerns generalised myasthenia gravis therapy
Company is focused on endocannabinoid system treatments
Data supports Poolbeg’s strategic expansion of POLB 001
License agreement concerns development of cell therapies for corneal blindness
Aston University to create the Aston Institute for Membrane Excellence
EUR 20m to identify new targets and develop first in class drugs
Companies collaborate to launch walk-in pain clinic
CellVoyant’s platform combines AI with live cell imaging